Synthesis of novel substituted 7-(benzylideneamino)-4-methyl-2H-chromen-2- one derivatives as anti-inflammatory and analgesic agents

Archiv der Pharmazie

Volumn 341, Issue 11, 2008, Pages 696-700

  Ronad, Pradeepkumar M ^a,d   Dharbamalla, Satyanarayana ^b   Hunshal, Rajesh ^c   Maddi, Veeresh ^a  

^a KLE'S College of Pharmacy   (India)

^b NITTE DEEMED TO BE UNIVERSITY   (India)

^c Karnataka Institute of Medical Science ^*  (India)

^d KLES's College of Pharmacy   (India)

Author keywords

2H chromen 2 ones; 7 Amino 4 methylcoumarin; Analgesic activity; Anti inflammatory activity; Schiff base

Indexed keywords

7 (2,4 DICHLOROBENZYLIDENEAMINO) 4 METHYL 2H CHROMEN 2 ONE; 7 (4 BROMOBENZYLIDENEAMINO) 4 METHYL 2H CHROMEN 2 ONE; 7 (4 CHLOROBENZYLIDENEAMINO) 4 METHYL 2H CHROMEN 2 ONE; 7 (BENZYLIDENEAMINO) 4 METHYL 2H CHROMEN 2 ONE DERIVATIVE; CHROMENE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOPYRANS; COUMARINS; DRUG EVALUATION, PRECLINICAL; EDEMA; MICE; RATS; SCHIFF BASES; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57349119553     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800057     Document Type: Article

References (15)

1. A. Murakami, G. Gao, M. Omura, M. Yano, et al., Bioorg. Med. Chem. Lett. 2000, 10, 59-63.
2. A. K. Mitra, N. Karchaudhuri, S. K. Misra, A. K. Mukopadhyay, J. Ind. Chem. Soc. 1998, 75, 666-669.
3. H. H. Sayed, A. H. Shamroukh, A. E. Rashad, Acta Pharm. 2006, 56, 231-244.
4. C. J. Wang, Y. J. Hsieh, C. Y. Chu, Y. L. Lin, T. H. Tseng, Cancer Lett. 2002, 183, 163-169.
5. A. Najim, A. Iman Al-Masoudi, A. I. Ibrahim, et al., Acta Pharm. 2006, 56, 175-188.
6. S. Kirkiacharian, D. T. Thuy, S. Sicsic, R. Bakhchinian, et al., II Farmaco. 2002, 57, 703-706.
7. P. Silvester, J. Valentova, L. Bezakova, O. Marek, Neuro Endocrinol. Lett. 2006, 27(Suppl.2), 180-182.
8. T. A. Lewis, L. Bayless, J. B. Eckman, J. L. Ellis, et al., Bioorg. Med. Chem. Lett. 2004, 14, 2265-2273.
9. V. S. Maddi, K. S. Raghu, M. N. A. Rao, J. Pharm. Sci. 1992, 81(9), 964-966.
10. S. B. Girish, V. S. Maddi, S. N. Mamledesai, P. M. Ronad, et al., Arzneim. Forsch. (Drug Res.) 2008; (In press).
11. D. Robinson, Brackenwood and Great Britain inventors. BioCarb AB, Sweden, assignee."7-amino-4-methyl-coumarin-3-carboxyalkyl derivatives and fluorescent conjugates thereof" U.S. Patent No. 4956480. 1990 Sep.11.
12. J. E. Pretka, Wilmington and Del, inventors American Cyanamid Company, New York, assignee. "4-substituted-7-carboalkoxyaminocoumarin" U.S. Patent No. 3008969. 1961 Nov.14.
13. OECD/OCDC, OECD "Guidelines for testing of chemicals" Revised draft guidelines 423; acute oral toxicity class method, Revised document, October 2000.
14. C. A. Winter, E. A. Risley, G. W. Nuss, Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
15. R. Koster, M. Anderson, E. J. De Beer, Fed. Proc. 1959, 18, 412-413.